You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Azelaic acid - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for azelaic acid and what is the scope of patent protection?

Azelaic acid is the generic ingredient in three branded drugs marketed by Teva Pharms Usa, Leo Pharma As, Almirall, Actavis Labs Ut Inc, Encube, Glenmark Speclt, and Taro, and is included in eight NDAs. There are five patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Azelaic acid has one hundred and thirty-seven patent family members in twenty countries.

There are eight drug master file entries for azelaic acid. Nine suppliers are listed for this compound. There is one tentative approval for this compound.

Drug Prices for azelaic acid

See drug prices for azelaic acid

Recent Clinical Trials for azelaic acid

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Insel Gruppe AG, University Hospital BernPhase 2
Chang Gung Memorial HospitalPhase 1/Phase 2
South Valley UniversityN/A

See all azelaic acid clinical trials

Generic filers with tentative approvals for AZELAIC ACID
Applicant Application No. Strength Dosage Form
⤷  Sign Up⤷  Sign Up15%AEROSOL, FOAM;TOPICAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for azelaic acid
Paragraph IV (Patent) Challenges for AZELAIC ACID
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FINACEA Topical Foam azelaic acid 15% 207071 1 2017-09-14
FINACEA Gel azelaic acid 15% 021470 1 2012-07-27

US Patents and Regulatory Information for azelaic acid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Encube AZELAIC ACID azelaic acid GEL;TOPICAL 208724-001 Nov 19, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro AZELAIC ACID azelaic acid GEL;TOPICAL 210549-001 Aug 23, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Actavis Labs Ut Inc AZELAIC ACID azelaic acid GEL;TOPICAL 208011-001 Nov 19, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Leo Pharma As FINACEA azelaic acid AEROSOL, FOAM;TOPICAL 207071-001 Jul 29, 2015 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for azelaic acid

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leo Pharma As FINACEA azelaic acid AEROSOL, FOAM;TOPICAL 207071-001 Jul 29, 2015 ⤷  Sign Up ⤷  Sign Up
Almirall AZELEX azelaic acid CREAM;TOPICAL 020428-001 Sep 13, 1995 ⤷  Sign Up ⤷  Sign Up
Leo Pharma As FINACEA azelaic acid AEROSOL, FOAM;TOPICAL 207071-001 Jul 29, 2015 ⤷  Sign Up ⤷  Sign Up
Leo Pharma As FINACEA azelaic acid GEL;TOPICAL 021470-001 Dec 24, 2002 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for azelaic acid

Country Patent Number Title Estimated Expiration
South Africa 200711243 Vasoactive kit and composition and uses thereof ⤷  Sign Up
South Korea 20060113657 PENETRATING PHARMACEUTICAL FOAM ⤷  Sign Up
European Patent Office 2422768 Mousse pharmaceutique pénétrante (Penetrating pharmaceutical foam) ⤷  Sign Up
Mexico PA06006923 ESPUMA OLEAGINOSA FARMACEUTICA Y COSMETICA. (OLEAGINOUS PHARMACEUTICAL AND COSMETIC FOAM.) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.